Beliefs about cervical cancer and human papillomavirus (HPV) and acceptability of HPV vaccination among Chinese women in Hong Kong

Qualitative research: Analysis types and software tools

Jeffrey S. Beaudry · Evaluation Practice · 1991 · 2K citations

Natural Sciences, Information Systems, Software Engineering +13

Sustained efficacy up to 4·5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

Diane M. Harper, Eduardo L. Franco, Cosette M. Wheeler et al. · The Lancet · 2006 · 1.6K citations · Full text

Veterinary Medicine, Immunology, Oncology +16

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

Luisa L. Villa, Ronaldo Lúcio Rangel Costa, Carlos Alberto Petta et al. · The Lancet Oncology · 2005 · 1.6K citations

Veterinary Medicine, Infectious Diseases, Oncology +17

Against which human papillomavirus types shall we vaccinate and screen? the international perspective

Núbia Muñóz, F. Xavier Bosch, Xavier Castellsagué et al. · International Journal of Cancer · 2004 · 1.1K citations · Full text

Medicine, Infectious Diseases, Oncology +17

Evaluation of Human Papillomavirus Testing in Primary Screening for Cervical Abnormalities

Shalini Kulasingam, James P. Hughes, Nancy B. Kiviat et al. · JAMA · 2002 · 456 citations

Medicine, Gynecology, Pathology +17